-
MFC Industrial Announces New CFO Appointment
Friday, June 27, 2014 - 7:40am | 108MFC Industrial Ltd. ("MFC" or the "Company") (NYSE: MIL) is pleased to announce that Samuel Morrow has been appointed Chief Financial Officer of the Company. Mr. Morrow replaces James Carter, who will continue with the Company as Vice President, Finance,focusing on the Company's resource interests...
-
Morning Market Movers
Tuesday, April 29, 2014 - 9:43am | 397Amicus Therapeutics (NASDAQ: FOLD) climbed 28.26% to $2.36 after the company reported positive 12- and 24-month data from Phase 3 Fabry monotherapy study 011. Orbital Sciences (NYSE: ORB) shares rose 25.47% to $33.34 after the company and Allian Techsystems' (NYSE: ATK) Aerospace and Defense...
-
British Columbia Supreme Court Prohibitis Kellogg Group From Trying to Take Control of MFC Board
Monday, December 23, 2013 - 6:50am | 80;MFC Industrial (NYSE: MIL) today announced that on December 20, 2013, the British Columbia Supreme Court issued an injunction against Peter Kellogg / IAT Reinsurance Company, Ltd. (the "Kellogg Group") and others prohibiting the Kellogg Group from trying to improperly take control of MFC's board...
-
Glass Lewis Recommends Against Peter Kellogg;s Attempt to Improperly Take Control of MFC's Board
Wednesday, December 18, 2013 - 6:48am | 180MFC Industrial (NYSE: MIL) today announced that the other leading independent proxy advisory and corporate governance firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that MFC shareholders vote "AGAINST" Peter Kellogg / IAT Reinsurance Company, Ltd.'s (the "Kellogg Group") attempt to...
-
MFC Board Adopts Rights Plan
Monday, November 11, 2013 - 12:31pm | 209MFC Industrial (NYSE: MIL) announces that its board of directors has adopted a shareholder rights plan (the "Plan"). The Plan is designed to encourage the fair and equal treatment of shareholders in connection with any plan to acquire effective control of the Company. Among other things, the Plan...
-
Luminex Corporation Receives FDA and European Clearance for a New Personalized Medicine Genotyping Assay, xTAG CYP2C19 Kit
Monday, September 23, 2013 - 4:06pm | 519Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA and European clearance for a comprehensive genotyping assay, xTAG® CYP2C19 Kit. This new test enables a personalized approach to aid physicians in determining patient treatment plans based on certain genetic variants of...
-
Luminex Corporation Receives FDA and European Clearance for an Updated Version of Its Comprehensive Genotyping Assay, xTAG® CYP2D6 Kit
Monday, July 15, 2013 - 4:05pm | 545Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA and European clearance for a new version of xTAG CYP2D6 Kit. Additionally the company has submitted xTAG 2C19 Kit to FDA for review. Luminex is advancing its pharmacogenetic initiative for improved patient care. "Test...
-
EVERTEC Announces the Appointment of Teresita Loubriel Rosado to the Board of Directors
Monday, July 1, 2013 - 4:23pm | 381EVERTEC (NYSE: EVTC) today announced that Teresita Loubriel Rosado was appointed to the Company's Board of Directors effective as of June 30, 2013. Teresita Loubriel Rosado was a senior executive at Banco Popular for 30 years until her retirement in 2008 serving in various leadership positions...
-
Benzinga's Top Initiations
Tuesday, May 7, 2013 - 7:08am | 155Analysts at Piper Jaffray initiated coverage on shares of Rally Software Development Group (NASDAQ: RALY) with an “overweight” rating. The target price range for Rally Software Development is set to $23. Rally Software Development's shares closed at $19.32 yesterday. ISI Group initiated coverage...
-
Luminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel
Monday, April 15, 2013 - 8:32am | 378Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP). This is the first clinical assay to be cleared on MAGPIX. xTAG GPP is the first U.S. IVD cleared test that can simultaneously...
-
Earnings Scheduled For April 1, 2013
Monday, April 1, 2013 - 4:12am | 407Cal-Maine Foods (NASDAQ: CALM) is projected to report its Q3 earnings at $1.40 per share on revenue of $321.40 million. Multiband (NASDAQ: MBND) is estimated to post its Q4 earnings at $0.04 per share on revenue of $73.87 million. Shoe Carnival (NASDAQ: SCVL) is projected to post its Q1 earnings...
-
UPDATE: Wedbush Initiates Luminex at Neutral, Top Line Growth Expected to Continue
Tuesday, March 26, 2013 - 9:10am | 220Wedbush analyst Zarak Khurshid published a report on Luminex (NASDAQ: LMNX) that initiated coverage with a Neutral rating and $17.00 price target. In the report, Wedbush wrote, "We believe LMNX will continue to post top-line growth (up 8% in 2013) with gradually improving EPS leverage, however,...
-
Benzinga's Top Initiations
Tuesday, March 26, 2013 - 7:29am | 149Analysts at Bank of America initiated coverage on shares of ON Semiconductor Corporation (NASDAQ: ONNN) with a “buy” rating. The target price range for ON Semiconductor is set to $11. ON Semiconductor's shares closed at $8.19 yesterday. Euro Pacific Capital initiated coverage on shares of Danaos...
-
Luminex Wins FDA Clearance for Xtag Gastro Pathogen Paenl
Tuesday, January 15, 2013 - 9:33am | 152Luminex Corporation (NASDAQ: LMNX) announced today that it has received FDA clearance for its xTAG Gastrointestinal Pathogen Panel (GPP), the first comprehensive molecular diagnostic assay that tests for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a...
-
Earnings Scheduled For November 14, 2012
Wednesday, November 14, 2012 - 3:43am | 566Abercrombie & Fitch Co (NYSE: ANF) is projected to report its Q3 earnings at $0.59 per share on revenue of $1.11 billion. NetApp (NASDAQ: NTAP) is expected to report its Q2 EPS at $0.48 on revenue of $1.54 billion. Aegean Marine Petroleum Network (NYSE: ANW) is estimated to post its Q3 EPS at...